Latest Period
Q4 2025
Security Snapshot
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) Institutional Ownership
CUSIP: 59503A204
13F Institutional Holders and Ownership History from Q3 2018 to Q1 2026
Institutions Reporting
71
Shares (Excl. Options)
11,422,467
Price
$2.00
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common stock, par value $0.01 per share
- Symbol
- MBOT on Nasdaq
- Shares outstanding
- 73,197,378
- Price per share
- $2.35
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 11,422,467
- Total reported value
- $22,844,684
- % of total 13F portfolios
- 0%
- Share change
- +2,295,148
- Value change
- +$3,310,309
- Number of holders
- 71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share is tracked under CUSIP 59503A204.
- 71 institutions reported positions in Q4 2025.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 71 to 16 between Q4 2025 and Q1 2026.
- Reported value moved from $22,844,684 to $2,349,530.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 71 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 59503A204?
CUSIP 59503A204 identifies MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 59503A204:
Significant Owners of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 8.2% | $12,004,370 | +$12,004,370 | 6,002,185 | Mitchell P. Kopin | 15 Jan 2026 | ||
| VANGUARD GROUP INC | 4.4% | -20% | $7,147,861 | +$893,415 | 2,343,561 | +14% | The Vanguard Group | 30 Sep 2025 |
| CVI Investments, Inc. | 4.9% | -20% | $4,780,994 | +$1,487,280 | 1,824,807 | +45% | CVI Investments, Inc. | 31 Mar 2025 |
As of 31 Dec 2025, 71 institutional investors reported holding 11,422,467 shares of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT). This represents 16% of the company’s total 73,197,378 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.5% | 3,329,721 | +42% | 0% | $6,659,442 |
| CIBC Private Wealth Group LLC | 2% | 1,480,000 | +1.8% | 0.01% | $2,960,000 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.7% | 1,245,123 | -0.39% | 0% | $2,490,246 |
| BlackRock, Inc. | 1.2% | 868,652 | +77% | 0% | $1,737,304 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 761,995 | +54% | 0% | $1,524,381 |
| DNB Asset Management AS | 0.93% | 677,498 | +178% | 0% | $1,354,996 |
| UBS Group AG | 0.61% | 445,132 | +119% | 0% | $890,264 |
| STIFEL FINANCIAL CORP | 0.36% | 265,990 | +69% | 0% | $531,980 |
| 683 Capital Management, LLC | 0.35% | 256,033 | 0.04% | $512,066 | |
| STATE STREET CORP | 0.28% | 207,169 | -0.62% | 0% | $414,338 |
| AlphaCentric Advisors LLC | 0.27% | 200,000 | 0% | 0.4% | $400,000 |
| JANE STREET GROUP, LLC | 0.27% | 197,408 | +1.9% | 0% | $394,816 |
| OMERS ADMINISTRATION Corp | 0.2% | 146,000 | 0% | $292,000 | |
| Qube Research & Technologies Ltd | 0.18% | 131,696 | 0% | $263,392 | |
| NORTHERN TRUST CORP | 0.16% | 114,205 | +43% | 0% | $228,410 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.15% | 111,000 | 0% | $222,000 | |
| SIMPLEX TRADING, LLC | 0.1% | 71,227 | +255% | 0% | $142,454 |
| MORGAN STANLEY | 0.09% | 68,972 | +779% | 0% | $137,944 |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 61,098 | -2.1% | 0% | $122,196 |
| BARCLAYS PLC | 0.08% | 59,377 | +5937600% | 0% | $118,754 |
| Virtu Financial LLC | 0.08% | 58,674 | 0% | $117,000 | |
| LPL Financial LLC | 0.07% | 47,932 | -4% | 0% | $95,864 |
| MILLENNIUM MANAGEMENT LLC | 0.06% | 46,805 | -45% | 0% | $93,610 |
| Lighthouse Investment Partners, LLC | 0.06% | 41,100 | 0% | $82,200 | |
| Hilltop Holdings Inc. | 0.05% | 35,764 | 0% | 0% | $71,528 |
Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 975,163 | $2,349,530 | +$934,574 | $2.41 | 16 |
| 2025 Q4 | 11,422,467 | $22,844,684 | +$3,310,309 | $2.00 | 71 |
| 2025 Q3 | 9,849,602 | $30,051,548 | +$16,711,553 | $3.05 | 67 |
| 2025 Q2 | 4,386,909 | $11,055,709 | +$5,764,677 | $2.52 | 47 |
| 2025 Q1 | 2,156,269 | $3,255,605 | +$1,699,280 | $1.51 | 41 |
| 2024 Q4 | 1,103,488 | $1,235,663 | +$63,070 | $1.12 | 34 |
| 2024 Q3 | 1,044,132 | $933,420 | -$46,041 | $0.89 | 23 |
| 2024 Q2 | 1,085,208 | $1,107,053 | -$449,318 | $1.02 | 33 |
| 2024 Q1 | 1,447,970 | $1,768,115 | -$281,766 | $1.23 | 31 |
| 2023 Q4 | 1,519,532 | $2,490,748 | +$867,449 | $1.64 | 30 |
| 2023 Q3 | 1,000,057 | $1,398,056 | -$857,178 | $1.39 | 25 |
| 2023 Q2 | 1,236,959 | $3,364,899 | -$460,248 | $2.72 | 25 |
| 2023 Q1 | 1,415,902 | $2,944,553 | -$152,124 | $2.08 | 25 |
| 2022 Q4 | 1,488,966 | $4,481,066 | +$2,064,567 | $3.01 | 21 |
| 2022 Q3 | 803,086 | $3,837,000 | +$2,761 | $4.78 | 16 |
| 2022 Q2 | 702,489 | $3,605,000 | -$247,792 | $5.13 | 16 |
| 2022 Q1 | 741,045 | $4,646,000 | +$150,132 | $6.27 | 18 |
| 2021 Q4 | 812,545 | $6,094,000 | +$265,795 | $7.50 | 18 |
| 2021 Q3 | 777,709 | $5,467,007 | +$107,409 | $7.03 | 16 |
| 2021 Q2 | 754,563 | $5,992,008 | -$382,067 | $7.94 | 21 |
| 2021 Q1 | 794,962 | $6,765,734 | +$295,356 | $8.51 | 20 |
| 2020 Q4 | 766,370 | $5,280,007 | -$45,186 | $6.89 | 16 |
| 2020 Q3 | 772,286 | $5,931,008 | -$23,065 | $7.71 | 16 |
| 2020 Q2 | 682,819 | $4,718,007 | -$1,382,287 | $6.91 | 13 |
| 2020 Q1 | 701,275 | $3,888,006 | +$236,511 | $5.51 | 19 |
| 2019 Q4 | 643,351 | $6,542,051 | +$350,924 | $10.16 | 16 |
| 2019 Q3 | 613,439 | $3,251,026 | -$112,684 | $5.30 | 18 |
| 2019 Q2 | 635,786 | $3,270,026 | +$172,218 | $5.13 | 16 |
| 2019 Q1 | 601,769 | $4,664,039 | +$3,059,819 | $7.75 | 15 |
| 2018 Q4 | 221,530 | $380,009 | -$32,735 | $1.72 | 13 |
| 2018 Q3 | 122,245 | $909,038 | +$909,038 | $7.55 | 11 |